Article
Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis.
BMC immunology - 30 Mar 2010
McNamara Lucy A, He Yongqun, Yang Zhenhua
Abstract excerpt
BACKGROUND: The Mtb72f subunit vaccine for tuberculosis, currently in clinical trials, is hoped to provide improved protection compared to the current BCG vaccine. It is not clear, however, whether Mtb72f would be equally protective in the different human populations suffering from a high burden...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
